WHO made big revelation! Remdesivir not helpful while Covid treatment
World Health Organization declares that Remdesivir is not helpful enough. Morality rate is not decreasing even after use of this drug.
New Delhi: There is a bad news about the Corona virus medicine that Remdesivir, a drug from the American pharma company Gilead, was believed to be effective to some extent in the treatment of covid-19 infection.
Now the World Health Organization (WHO) has prescribed this drug but in corona treatment failed to prevent deaths. Remdesivir is proving effective on the patients of covid-19 when the news came, there were hope among the people.
Remdesivir big revelation:
Investigations had shown that this drug could cure patients infected with the corona virus quickly. This had happened in some cases, but now this statement of the World Health Organization has given a big blow to the patients being treated for corona from Remdesivir.
Not helping much in treatment of covid patient:
WHO carried out a clinical trial of Remdesivir on 11,266 adult patients from 30 countries. It included four possible drug regimens including Remdesivir as well as hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon. Whose effects were evaluated.
In the study on Thursday, the WHO found that it did not affect the 28-day mortality or recovery of hospitalized patients with Covid-19. The details of the clinical trial are yet to be reviewed in detail. This primary study has been uploaded to the preprint server (medRxiv).
WHO chief scientist Soumya Swaminathan said on Wednesday that hydroxychloroquine and lopinavir/risinavir halted in June during the study after it proved ineffective. But related trials are underway in more than 500 hospitals and 30 countries. Swaminathan said, “We are monitoring monoclonal anti-bodies. Its results will be understood in a few days. '
According to Soumya Swaminathan, the corona vaccine will arrive by the end of this year or early next year. Swaminathan said on Monday, "40 companies are currently developing vaccines under the WHO banner. 10 of them are in the third phase of trial." We will have the vaccine by the end of 2020 or early 2021.